Asarina Pharma AB (OSTO:ASAP) Ending Cash Position : kr0.00 Mil (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Asarina Pharma AB Ending Cash Position?

Asarina Pharma AB's Ending Cash Position for the quarter that ended in Jun. 2023 was kr0.00 Mil.

Asarina Pharma AB's quarterly Ending Cash Position declined from Jun. 2022 (kr12.30 Mil) to Dec. 2022 (kr0.00 Mil) but then stayed the same from Dec. 2022 (kr0.00 Mil) to Jun. 2023 (kr0.00 Mil).

Asarina Pharma AB's annual Ending Cash Position declined from Dec. 2020 (kr58.50 Mil) to Dec. 2021 (kr21.72 Mil) and declined from Dec. 2021 (kr21.72 Mil) to Dec. 2022 (kr13.58 Mil).

Asarina Pharma AB Ending Cash Position Historical Data

The historical data trend for Asarina Pharma AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asarina Pharma AB Ending Cash Position Chart

Asarina Pharma AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Ending Cash Position

Get a 7-Day Free Trial

141.54

129.51

58.50

21.72

13.58

Asarina Pharma AB Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Jun23
Ending Cash Position	Get a 7-Day Free Trial															21.72	16.29	12.30	-	-

Asarina Pharma AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Asarina Pharma AB's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	21.715	+	-8.138
	=	13.58

Asarina Pharma AB's Ending Cash Position for the quarter that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0.00

Asarina Pharma AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Asarina Pharma AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Asarina Pharma AB (OSTO:ASAP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asarina Pharma AB (OSTO:ASAP) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

APS:Germany

Address

Fogdevreten 2, Karolinska Institutet Science Park, Solna, SWE, SE-171 65

Website

https://www.asarinapharma.com

Asarina Pharma AB is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion and neurological disorders. Its product pipeline is built on over 40 years of research into llopregnanolone-related neurological disorders. With the new family of GAMSA compounds (GABA-A Modulating Steroid Antagonists) the company aims to deliver a new generation of efficacious and safe drugs for still widely untreated neuroendocrinological conditions.

Asarina Pharma AB (OSTO:ASAP) Headlines

No Headlines